Serine Pharma, Mysore, Karnataka, India

Ceftri TZ InjectionProducts

Menu

CEFTRI TZ

CEFTRITM TZ (1000mg/125mg Injection)

SALT COMPOSITION

Ceftriaxone (1000mg) + Tazobactam (125mg)

STORAGE

Store below 30°C

PRODUCT INTRODUCTION

CEFTRI TZ 1000mg/125mg Injection is a combination medicine. It is prescribed to treat various types of bacterial infections. It fights against the microorganisms to prevent their growth and further spread of the infection.

CEFTRI TZ 1000mg/125mg Injection should only be administered under the supervision of a healthcare professional. Do not miss any scheduled appointments for taking this medicine. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine.

Some common side effects of this medicine are nausea, vomiting, diarrhea, indigestion, etc. If any of the side effects get aggravated, you must consult your doctor immediately. If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help.

Before taking this medicine, you should tell your doctor if you are taking any medicines for any health condition. Pregnant or breastfeeding women should also consult with their doctor before taking it. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine. It usually does not impair your ability to drive, but you should not drive if it makes you feel sleepy or dizzy. You must take adequate rest for a faster recovery, also take a healthy diet and drink plenty of water. Your doctor may ask for a few laboratory and diagnostic tests to know the effects of the medicine on your body.

USES OF CEFBACT T INJECTION:

Bacterial Infection

BENEFITS OF CEFTRI TZ 1000mg/125mg Injection

In Bacterial infections

CEFTRI TZ 1000mg/125mg Injection 1000mg/125mg Injection helps treat infections that are caused by bacteria. It contains two medicines, Ceftriaxone, and Tazobactam. Ceftriaxone stops the growth of infection-causing bacteria. Tazobactam enhances the activity of Ceftriaxone against the bacteria as well as reduces resistance of the bacteria to the antibiotic. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all the infectious bacteria are killed and do not become resistant.

SIDE EFFECTS OF CEFTRI TZ 1000mg/125mg Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them. Common side effects are Diarrhea, Increased Liver Enzymes, Allergic Reaction, Rash

HOW TO USE CEFTRI TZ 1000mg/125mg INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

HOW CEFTRI TZ 1000mg/125mg INJECTION WORKS

CEFTRI TZ 1000mg/125mg Injection is a combination of two medicines: Ceftriaxone and Tazobactum. Ceftriaxone is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Tazobactum is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftriaxone against bacteria.

SAFETY ADVICE

Alcohol: Consuming alcohol with CEFTRI TZ 1000mg/125mg Injection does not cause any harmful side effects.

Pregnancy: CEFTRI TZ 1000mg/125mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding: CEFTRI TZ 1000mg/125mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving: CEFTRI TZ 1000mg/125mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney: There is limited information available on the use of CEFTRI TZ 1000mg/125mg Injection in patients with kidney disease. Please consult your doctor.

Liver: CEFTRI TZ 1000mg/125mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of CEFTRI TZ 1000mg/125mg Injection may be needed. Please consult your doctor.

Dose adjustment of CEFTRI TZ 1000mg/125mg Injection is not recommended in patients with mild to moderate liver disease.

WHAT IF YOU FORGET TO TAKE CEFBACT T INJECTION?

If you miss a dose of CEFTRI TZ 1000mg/125mg Injection please consult your doctor.

REFERENCES

  1. https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases
  2. https://www.fda.gov
  3. PubMed/NCBI
  4. Medscape.com
  5. Micromedex.com
  6. Product Information: Ceftriaxone sodium intramuscular, intravenous injection, ceftriaxone sodium intramuscular, intravenous injection. Remedy Repack, Inc (per DailyMed), Indiana, PA, 2023.
  7. Tunkel AR, Hartman BJ, Kaplan SL, et al: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39(9):1267-1284. PubMed Abstract: http://www.ncbi.nlm.nih.gov/
  8. Mermel LA , Allon M , Bouza E , et al: Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45. PubMed Abstract: http://www.ncbi.nlm.nih.gov/
  9. Baddour LM , Wilson WR , Bayer AS , et al: Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132(15):1435-1486. PubMed Abstract: http://www.ncbi.nlm.nih.gov/
  10. Product Information: Ceftriaxone sodium intramuscular, intravenous injection, ceftriaxone sodium intramuscular, intravenous injection. Hospira Inc (per DailyMed), Lake Forest, IL, 2020.
  11. Steele RW, Eyre LB, Bradsher RW, et al: Pharmacokinetics of ceftriazone in pediatric patients with meningitis. Antimicrob Agents Chemother 1983; 23:191-194.
  12. Spencer S, Ipema H, Hartke P, et al: Intravenous push administration of antibiotics: literature and considerations. Hosp Pharm 2018; 53(3):157-169. PubMed Abstract: http://www.ncbi.nlm.nih.gov/

Disclaimer

The content of the information is Authenticated, well referenced, expert-reviewed which are accurate and trust worthy. The information provided here is for informational purposes only for the benefit of the consumer. This may not include all of the information regarding specific medical problems / health conditions, laboratory tests, medications, all potential side effects, drug interactions, cautions, alerts, etc.  If you have any questions concerning any illness or medication, please speak with your physician or pharmacist.

Prepared by

1 Dr. Mohammed Ali  M Pharm PhD

2 Dr.  Baharul Islam Hadiari,  Pharm D

Download

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Scroll to Top